Switch to:

Trevi Therapeutics EV-to-EBIT

: -0.59 (As of Today)
View and export this data going back to 2019. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Trevi Therapeutics's Enterprise Value is $17.58 Mil. Trevi Therapeutics's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was $-29.83 Mil. Therefore, Trevi Therapeutics's EV-to-EBIT for today is -0.59.

NAS:TRVI' s EV-to-EBIT Range Over the Past 10 Years
Min: -7.72   Med: 0   Max: 1.11
Current: -0.59

-7.72
1.11

During the past 3 years, the highest EV-to-EBIT of Trevi Therapeutics was 1.11. The lowest was -7.72. And the median was 0.00.

NAS:TRVI's EV-to-EBIT is ranked lower than
99.99% of the 254 Companies
in the Biotechnology industry.

( Industry Median: 34.64 vs. NAS:TRVI: -0.59 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Trevi Therapeutics's Enterprise Value for the quarter that ended in Sep. 2020 was $33.87 Mil. Trevi Therapeutics's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was $-29.83 Mil. Trevi Therapeutics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2020 was -88.08%.


Trevi Therapeutics EV-to-EBIT Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Trevi Therapeutics Annual Data
Dec17 Dec18 Dec19
EV-to-EBIT 0.00 0.00 -0.38

Trevi Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.67 -0.38 -0.21 0.00 0.00

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Trevi Therapeutics EV-to-EBIT Distribution

* The bar in red indicates where Trevi Therapeutics's EV-to-EBIT falls into.



Trevi Therapeutics EV-to-EBIT Calculation

Trevi Therapeutics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=17.578/-29.834
=-0.59

Trevi Therapeutics's current Enterprise Value is $17.58 Mil.
Trevi Therapeutics's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was -6.541 (Dec. 2019 ) + -8.639 (Mar. 2020 ) + -7.413 (Jun. 2020 ) + -7.241 (Sep. 2020 ) = $-29.83 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Trevi Therapeutics  (NAS:TRVI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Trevi Therapeutics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2020 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2020 ) =EBIT / Enterprise Value (Q: Sep. 2020 )
=-29.834/33.87205
=-88.08 %

Trevi Therapeutics's Enterprise Value for the quarter that ended in Sep. 2020 was $33.87 Mil.
Trevi Therapeutics's EBIT for the trailing twelve months (TTM) ended in Sep. 2020 was -6.541 (Dec. 2019 ) + -8.639 (Mar. 2020 ) + -7.413 (Jun. 2020 ) + -7.241 (Sep. 2020 ) = $-29.83 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Trevi Therapeutics EV-to-EBIT Related Terms


Trevi Therapeutics EV-to-EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)